US Broker Ratings

Astrana Health Inc. (ASTH) Stock Analysis: A 105% Upside Potential Amidst Robust Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company headquartered in Alhambra, California, is emerging as a compelling investment opportunity within the medical care facilities industry. With a market capitalization..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Landscape with a 7.73% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is a key player in the burgeoning virtual healthcare sector, offering a range of integrated care solutions and mental health services via its BetterHelp platform...

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 35% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is commanding attention with a compelling potential upside of..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating High Growth in Biotechnology with Significant Challenges

Ascentage Pharma Group International (NASDAQ: AAPG), a prominent player in the biotechnology sector, is making waves with its ambitious pipeline targeting cancers, chronic hepatitis B, and age-related diseases. Headquartered in..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a 3.36% Potential Upside Amidst Healthcare Sector Dynamics

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates senior living communities across the United States. With a market capitalization of $1.81 billion, the company..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A Biotech with 182.60% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has captured investor attention with its promising drug pipeline and significant upside potential. The company, based in San Diego, is focused..

PACS Group, Inc. (PACS) Stock Analysis: A 162% Upside Potential in Healthcare

PACS Group, Inc. (NASDAQ: PACS), a prominent player in the healthcare sector, is catching the eye of investors with a staggering potential upside of 162.48%. Operating in the medical care..

Indivior PLC (INDV) Stock Analysis: Exploring a 23.4% Upside Potential in the Healthcare Sector

Indivior PLC (INDV), a notable player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry, presents an intriguing opportunity for investors seeking exposure to the opioid..

Merus N.V. (MRUS) Stock Analysis: Strong Buy Ratings and Promising 44% Upside Potential

Merus N.V. (NASDAQ: MRUS) is gaining attention in the biotechnology sector with its promising pipeline of bispecific antibody therapeutics. Based in the Netherlands, this clinical-stage immuno-oncology company is making significant..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: 48.55% Potential Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (AMRX) presents a compelling case with a potential upside of 48.55%, according to recent analyst ratings. This global biopharmaceutical..

BGM Group Ltd. (BGM): Investor Outlook Amidst a Challenging Revenue Landscape in the Healthcare Sector

BGM Group Ltd. (BGM), a key player in the healthcare sector specializing in drug manufacturing, is navigating a complex market environment. With a market capitalization of $2.13 billion, this China-based..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling the 132% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical innovator, is making waves in the biotechnology sector with its ambitious focus on neurodegenerative and lysosomal storage diseases. Despite its current stock price..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Significant Upside Potential Amidst Innovative Genetic Medicines Development

Beam Therapeutics Inc. (NASDAQ: BEAM) is steadily carving out its niche in the biotechnology sector with its focus on precision genetic medicines. As the company continues to develop groundbreaking treatments..

Clover Health Investments (CLOV): Analyzing the 50% Upside Potential in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) is steadily carving a niche in the healthcare sector, focusing primarily on Medicare Advantage plans in the United States. Based in Wilmington, Delaware, Clover..

Immunovant, Inc. (IMVT) Stock Analysis: Seizing a 145% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a dynamic player in the biotechnology sector, has been making waves with its ambitious pursuits in the field of autoimmune therapies. As a clinical-stage immunology company,..

GoodRx Holdings, Inc. (GDRX): Analyst Consensus and a 32.98% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a key player in the healthcare sector, operates within the Health Information Services industry. With its headquarters in Santa Monica, California, GoodRx is well-known for..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring the 75% Potential Upside

For investors eyeing the healthcare sector, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) presents an intriguing opportunity, particularly with its remarkable potential upside of 75.44%. Specializing in biotechnology, Tarsus is on a..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with a 20% Revenue Growth

Galapagos NV (NASDAQ: GLPG), a Belgian biotechnology company focusing on oncology and immunology, is capturing investor attention with a notable 20.1% revenue growth despite facing challenges typical of the volatile..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 70% Potential Upside with Strong Buy Ratings

In the competitive landscape of the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) stands out within the realm of medical instruments and supplies. With a market capitalization of $1.45 billion, this..

Zai Lab Limited (ZLAB): Analyst Ratings Signal 56% Upside Potential Amid Robust Biotech Portfolio

Investors seeking value in the healthcare sector may find Zai Lab Limited (NASDAQ: ZLAB) an intriguing prospect, as analysts project a substantial 56.84% upside potential for the stock. This China-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds